Evaluation of networks of randomized trials
Top Cited Papers
- 9 October 2007
- journal article
- research article
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 17 (3) , 279-301
- https://doi.org/10.1177/0962280207080643
Abstract
Randomized trials may be designed and interpreted as single experiments or they may be seen in the context of other similar or relevant evidence. The amount and complexity of available randomized evidence vary for different topics. Systematic reviews may be useful in identifying gaps in the existing randomized evidence, pointing to discrepancies between trials, and planning future trials. A new, promising, but also very much debated extension of systematic reviews, mixed treatment comparison (MTC) meta-analysis, has become increasingly popular recently. MTC meta-analysis may have value in interpreting the available randomized evidence from networks of trials and can rank many different treatments, going beyond focusing on simple pairwise-comparisons. Nevertheless, the evaluation of networks also presents special challenges and caveats. In this article, we review the statistical methodology for MTC meta-analysis. We discuss the concept of inconsistency and methods that have been proposed to evaluate it as well as the methodological gaps that remain. We introduce the concepts of network geometry and asymmetry, and propose metrics for the evaluation of the asymmetry. Finally, we discuss the implications of inconsistency, network geometry and asymmetry in informing the planning of future trials.Keywords
This publication has 62 references indexed in Scilit:
- Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple TreatmentsJNCI Journal of the National Cancer Institute, 2006
- Indirect comparisons: the mesh and mess of clinical trialsThe Lancet, 2006
- Systematic reviews: when is an update an update?The Lancet, 2006
- Epidemiology and reporting of randomised trials published in PubMed journalsThe Lancet, 2005
- Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over timeEuropean Journal Of Cancer, 2003
- Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway?BMJ, 2003
- Network meta‐analysis for indirect treatment comparisonsStatistics in Medicine, 2002
- A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication ratesAlimentary Pharmacology & Therapeutics, 1999
- The quality of medical evidence in hematology-oncologyThe American Journal of Medicine, 1999
- Users' Guides to the Medical LiteratureJAMA, 1995